• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Have We Found the "Holy Grail" That May Predict Response to Immunotherapy in Hepatocellular Carcinoma?

作者信息

Brandi Giovanni, Tovoli Francesco, Tavolari Simona

机构信息

Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy; Division of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, Istituto di Ricovero e Cura a Carattere Scientifico, Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

出版信息

Gastroenterology. 2023 Jan;164(1):15-18. doi: 10.1053/j.gastro.2022.10.030. Epub 2022 Nov 9.

DOI:10.1053/j.gastro.2022.10.030
PMID:36334819
Abstract
摘要

相似文献

1
Have We Found the "Holy Grail" That May Predict Response to Immunotherapy in Hepatocellular Carcinoma?我们是否找到了可能预测肝细胞癌免疫治疗反应的“圣杯”？
Gastroenterology. 2023 Jan;164(1):15-18. doi: 10.1053/j.gastro.2022.10.030. Epub 2022 Nov 9.
2
Hepatocellular carcinoma in the era of immunotherapy.免疫治疗时代的肝细胞癌
Curr Probl Cancer. 2018 Jan-Feb;42(1):40-48. doi: 10.1016/j.currproblcancer.2017.10.007. Epub 2017 Nov 15.
3
[Current status and progress of immunotherapy for hepatocellular carcinoma].
Zhonghua Gan Zang Bing Za Zhi. 2003 Dec;11(12):757.
4
Immunotherapy in hepatocellular carcinoma.
Lancet. 2000 Sep 2;356(9232):784-5. doi: 10.1016/S0140-6736(00)02648-9.
5
[What are the limits of efficacy for immunotherapy against hepatocellular carcinoma and its clinical availability].[肝癌免疫治疗的疗效极限及其临床可用性是什么]
Zhonghua Gan Zang Bing Za Zhi. 2014 May;22(5):393-6. doi: 10.3760/cma.j.issn.1007-3418.2014.06.001.
6
Immunotherapy as a Downstaging Tool for Liver Transplantation in Hepatocellular Carcinoma.免疫疗法作为肝细胞癌肝移植的降期工具
Am J Gastroenterol. 2021 Dec 1;116(12):2478-2480. doi: 10.14309/ajg.0000000000001391.
7
[Immunotherapy for hepatocellular carcinoma using dendritic cells].[使用树突状细胞的肝细胞癌免疫疗法]
Nihon Rinsho. 2001 Oct;59 Suppl 6:693-8.
8
Targeting Neoantigens in Hepatocellular Carcinoma for Immunotherapy: A Futile Strategy?靶向肝细胞癌新抗原进行免疫治疗：一种徒劳的策略？
Hepatology. 2021 Jan;73(1):414-421. doi: 10.1002/hep.31279.
9
Dissecting the Tumor Microenvironment to Predict Immunotherapy Response in Hepatocellular Cancer.剖析肿瘤微环境以预测肝细胞癌的免疫治疗反应
Gastroenterology. 2022 Dec;163(6):1712-1713. doi: 10.1053/j.gastro.2022.08.024. Epub 2022 Aug 11.
10
[Immunotherapy of hepatocellular carcinoma].[肝细胞癌的免疫治疗]
Dtsch Med Wochenschr. 2001 Dec 21;126(51-52):1464-6. doi: 10.1055/s-2001-19215.

引用本文的文献

1
Characteristics and outcomes of primary and secondary resistance to immune checkpoint inhibitors in hepatocellular carcinoma.肝细胞癌中对免疫检查点抑制剂原发性和继发性耐药的特征及结局
Cancer Immunol Immunother. 2025 Jun 7;74(8):239. doi: 10.1007/s00262-025-04089-x.
2
Pathologic assessment of hepatocellular carcinoma in the era of immunotherapy: a narrative review.免疫治疗时代肝细胞癌的病理评估：一篇叙述性综述
Hepatobiliary Surg Nutr. 2024 Jun 1;13(3):472-493. doi: 10.21037/hbsn-22-527. Epub 2023 Apr 4.